201 related articles for article (PubMed ID: 15067378)
1. Effect of peroxisome proliferator-activated receptor alpha on human angiotensinogen promoter.
Shimamoto Y; Hirota K; Fukamizu A
Int J Mol Med; 2004 May; 13(5):729-33. PubMed ID: 15067378
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of the PXR gene: identification and characterization of a functional peroxisome proliferator-activated receptor alpha binding site within the proximal promoter of PXR.
Aouabdi S; Gibson G; Plant N
Drug Metab Dispos; 2006 Jan; 34(1):138-44. PubMed ID: 16243957
[TBL] [Abstract][Full Text] [Related]
3. Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level.
Lee GY; Kim NH; Zhao ZS; Cha BS; Kim YS
Biochem J; 2004 Mar; 378(Pt 3):983-90. PubMed ID: 14641110
[TBL] [Abstract][Full Text] [Related]
4. Cloning and characterization of the human beta2-glycoprotein I (beta2-GPI) gene promoter: roles of the atypical TATA box and hepatic nuclear factor-1alpha in regulating beta2-GPI promoter activity.
Wang HH; Chiang AN
Biochem J; 2004 Jun; 380(Pt 2):455-63. PubMed ID: 14984368
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor alpha and its response element are required but not sufficient for transcriptional activation of the mouse heart-type fatty acid binding protein gene.
Kawabe K; Saegusa H; Seto K; Urabe H; Motojima K
Int J Biochem Cell Biol; 2005 Jul; 37(7):1534-46. PubMed ID: 15833283
[TBL] [Abstract][Full Text] [Related]
6. Differentiation-dependent activation of the human intestinal alkaline phosphatase promoter by HNF-4 in intestinal cells.
Olsen L; Bressendorff S; Troelsen JT; Olsen J
Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G220-6. PubMed ID: 15831710
[TBL] [Abstract][Full Text] [Related]
7. Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB.
Inoue I; Itoh F; Aoyagi S; Tazawa S; Kusama H; Akahane M; Mastunaga T; Hayashi K; Awata T; Komoda T; Katayama S
Biochem Biophys Res Commun; 2002 Jan; 290(1):131-9. PubMed ID: 11779144
[TBL] [Abstract][Full Text] [Related]
8. The human organic anion transporter 2 gene is transactivated by hepatocyte nuclear factor-4 alpha and suppressed by bile acids.
Popowski K; Eloranta JJ; Saborowski M; Fried M; Meier PJ; Kullak-Ublick GA
Mol Pharmacol; 2005 May; 67(5):1629-38. PubMed ID: 15692145
[TBL] [Abstract][Full Text] [Related]
9. The activity of the activation function 2 of the human hepatocyte nuclear factor 4 (HNF-4alpha) is differently modulated by F domains from various origins.
Suaud L; Formstecher P; Laine B
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):161-9. PubMed ID: 10229671
[TBL] [Abstract][Full Text] [Related]
10. The human organic cation transporter-1 gene is transactivated by hepatocyte nuclear factor-4alpha.
Saborowski M; Kullak-Ublick GA; Eloranta JJ
J Pharmacol Exp Ther; 2006 May; 317(2):778-85. PubMed ID: 16436500
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the human SLC25A20 expression by peroxisome proliferator-activated receptor alpha in human hepatoblastoma cells.
Tachibana K; Takeuchi K; Inada H; Yamasaki D; Ishimoto K; Tanaka T; Hamakubo T; Sakai J; Kodama T; Doi T
Biochem Biophys Res Commun; 2009 Nov; 389(3):501-5. PubMed ID: 19748481
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 inhibits human peroxisome proliferator activated receptor alpha gene expression via CCAAT/enhancer-binding proteins in hepatocytes.
Chew CH; Chew GS; Najimudin N; Tengku-Muhammad TS
Int J Biochem Cell Biol; 2007; 39(10):1975-86. PubMed ID: 17616429
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of the small heterodimer partner on hepatocyte nuclear factor-4 mediates bile acid-induced repression of the human angiotensinogen gene.
Shimamoto Y; Ishida J; Yamagata K; Saito T; Kato H; Matsuoka T; Hirota K; Daitoku H; Nangaku M; Yamagata K; Fujii H; Takeda J; Fukamizu A
J Biol Chem; 2004 Feb; 279(9):7770-6. PubMed ID: 14672953
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the human PDZK1 expression by peroxisome proliferator-activated receptor alpha.
Tachibana K; Anzai N; Ueda C; Katayama T; Yamasaki D; Kirino T; Takahashi R; Ishimoto K; Komori H; Tanaka T; Hamakubo T; Ueda Y; Arai H; Sakai J; Kodama T; Doi T
FEBS Lett; 2008 Nov; 582(28):3884-8. PubMed ID: 18955051
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor alpha (PPARalpha) and agonist inhibit cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription.
Marrapodi M; Chiang JY
J Lipid Res; 2000 Apr; 41(4):514-20. PubMed ID: 10744771
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid stimulates primate but inhibits rodent alpha-fetoprotein gene promoter.
Nakabayashi H; Koyama Y; Sakai M; Li HM; Wong NC; Nishi S
Biochem Biophys Res Commun; 2001 Sep; 287(1):160-72. PubMed ID: 11549270
[TBL] [Abstract][Full Text] [Related]
17. Selectivity of fatty acid ligands for PPARalpha which correlates both with binding to cis-element and DNA binding-independent transactivity in Caco-2 cells.
Mochizuki K; Suruga K; Fukami H; Kiso Y; Takase S; Goda T
Life Sci; 2006 Dec; 80(2):140-5. PubMed ID: 17007889
[TBL] [Abstract][Full Text] [Related]
18. The ribosomal protein rpL11 associates with and inhibits the transcriptional activity of peroxisome proliferator-activated receptor-alpha.
Gray JP; Davis JW; Gopinathan L; Leas TL; Nugent CA; Vanden Heuvel JP
Toxicol Sci; 2006 Feb; 89(2):535-46. PubMed ID: 16280383
[TBL] [Abstract][Full Text] [Related]
19. Hypolipidemia induced by PPARalpha agonists: HNF-4alpha as an alternative to PPARalpha.
Bar-Tana J
Curr Opin Investig Drugs; 2004 Sep; 5(9):941-6. PubMed ID: 15503648
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins.
Schachtrup C; Emmler T; Bleck B; Sandqvist A; Spener F
Biochem J; 2004 Aug; 382(Pt 1):239-45. PubMed ID: 15130092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
